OMX30 1 620 0,2%  OMXH25 3 955 0,6%  OMXC20 954 1,0%  Dow 20 975 -0,1%  Nas 5 541 -0,1%  EUR 9,5555 0,0%  USD 8,7619 0,0%  Olja 51,6 0,2%  Guld 1 267 -0,4% 

Johnson & Johnson Aktie

123,55USD 0,11USD 0,09%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Johnson & Johnson

2016 2017e 2018e 2019e 2020e
Utdelning 3,15 3,35 3,56 3,80 3,84
Direktavkastning (i %) 2,71 2,74 2,91 3,11 3,14
PE-tal 17,24 17,23 15,97 15,07 14,30
Resultat/aktie 6,73 7,10 7,65 8,11 8,55
ytterligare nyheter

Analyser om Johnson & Johnson

Jun, 13 2016 Johnson & Johnson Neutral Goldman Sachs Group Inc.
ytterligare analyser

Johnson & Johnson Peer Group

Abbott Laboratories 43,81
0,1%
Alexion Pharmaceuticals 120,79
0,2%
AstraZeneca 537,50
0,2%
Bayer 108,05
-0,4%
Beiersdorf 91,07
0,7%
Celgene 125,12
-0,3%
Fresenius Medical Care 82,19
0,8%
Fresenius 74,33
-0,1%
GlaxoSmithKline 15,66
-2,1%
Johnson & Johnson 123,55
0,1%
Merck 62,71
0,6%
Merck 107,90
0,8%
MorphoSys 54,94
2,0%
Nestlé 77,55
0,5%
Novartis 76,15
0,6%
Pfizer 33,85
0,3%
Procter & Gamble 87,75
-2,5%
Roche 258,50
0,4%
STADA 64,50
-0,2%
Sanofi 85,65
0,7%
Unilever 47,97
-0,1%
pagehit

Lägg till instrument

Vad tycker du?

Profil Johnson & Johnsontill bolagsprofilen

Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Realtidskurs Johnson & Johnson

Bid
112,00
USD
Ask
123,54
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Johnson & Johnson i USDPUSH CHART

Kurs 123,55 USD 0,11 0,09 %
Kurstid 21:59:59
Datum 26.04.2017
Öppning 123,54
Gårdagen 123,55
Dagshögsta 124,26
Dagslägsta 123,46
52 v. högsta 129,00
52 v. lägsta 109,33
52 v. perf.
Volym (Antal) 312 813
Börsvärde (SEK) 2 949,01 Mrd
Börsen
Kurs för 123,55 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 082,53 SEK.

Till aktien Johnson & Johnson

Ticker
ISIN US4781601046
Index Dow Jones, BX Swiss - USA, S&P 100, NYSE US 100, S&P 500

Struktuerarde produkter på Johnson & Johnson

Produkttyp Antal
Certificates 2
Plain Vanilla Warrants 1

Johnson & Johnson Nyckeltal

Börsvärde i SEK 2 949,01 Mrd
Free float % 99,90
Antal aktier mio. 2 710,89
Cashflow/aktie i lokal valuta 6,47
Bokvärde/aktie i lokal valuta 27,40
60 dagar vola 12,92
PBV 4,24

Johnson & Johnson Historiska kurser

2017-04-26 123,55 312 813
2017-04-25 123,44 402 953
2017-04-24 122,90 304 972
2017-04-21 121,79 318 611
2017-04-20 121,89 460 714

Aktier i samma industri med bättre 1 års perf.

Exelixis Inc. 399,0 %
SIGA Technologies Inc. 315,0 %
Amylin Pharmaceuticals Inc. 264,9 %
Ariad Pharmaceuticals Inc. 260,2 %
EXACT Sciences Corp. 246,2 %